**Current World Health Organization Classification of ALL**

**B-lymphoblastic leukemia/lymphoma**

- B-lymphoblastic leukemia/lymphoma, NOS

- B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormalities

- B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2);  BCR-ABL1

- B-lymphoblastic leukemia/lymphoma with t(v;11q23.3); KMT2A rearranged

- B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1);  ETV6-RUNX1

- B-lymphoblastic leukemia/lymphoma with hyperdiploidy

- B-lymphoblastic leukemia/lymphoma with hypodiploidy

- B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3);  IL3-IGH

- B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);  TCF3-PBX1

- Provisional entity: B-lymphoblastic leukemia/lymphoma,  BCR-ABL1-like

- Provisional entity: B-lymphoblastic leukemia/lymphoma with  iAMP21

**T-lymphoblastic leukemia/lymphoma**

- Provisional entity: Early T-cell precursor lymphoblastic leukemia

- Provisional entity: Natural killer (NK) cell lymphoblastic leukemia/lymphoma